Top Pharmaceuticals companies in Ireland by EBITDA

This ranking features the top 15 Pharmaceuticals companies in Ireland ranked by EBITDA, totalling a EBITDA of USD 17.08 B, for January 15, 2025.
#
Name
EBITDA
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 9.19 B
Oct. 25, 2024 USD 85.25 4.23%

Ireland

2
USD 2.42 B
March 31, 2024 USD 42.18 0.76%

Ireland

3
USD 1.52 B
Dec. 31, 2023 USD 200.24 -8.14%

Ireland

4
USD 1.34 B
Sept. 30, 2024 USD 207.57 0.10%

Ireland

5
USD 1.32 B
Dec. 31, 2023 USD 93.99 0.60%

Ireland

6
USD 1.23 B
Dec. 31, 2023 USD 122.96 -0.16%

Ireland

7
USD 519.48 M
Dec. 31, 2023 USD 28.50 0.53%

Ireland

8
USD 121.84 M
Dec. 31, 2023 USD 2.05 2.67%

Ireland

9
USD 21.74 M
Dec. 31, 2023 USD 69.11 -2.10%

Ireland

10
USD -605.96 K
Dec. 31, 2023 USD 0.02 -6.17%

Ireland

11
USD -34.58 M
Dec. 31, 2023 USD 1.60 -2.44%

Ireland

12
USD -41.15 M
Dec. 31, 2023 USD 8.19 -1.92%

Ireland

13
USD -149.12 M
Dec. 31, 2023 USD 8.05 2.94%

Ireland

14
USD -190.11 M
Dec. 31, 2023 USD 12.67 -3.50%

Ireland

15
USD -192.72 M
Dec. 31, 2023 USD 3.72 -0.53%

Ireland

Frequently Asked Questions
  • Which Pharmaceuticals company in Ireland has the highest EBITDA ?

    The Pharmaceuticals company in Ireland with the highest EBITDA is Medtronic plc (NYSE: MDT) at USD 9.19 B.

  • Which Pharmaceuticals company in Ireland has the lowest EBITDA ?

    The Pharmaceuticals company in Ireland with the lowest EBITDA is Mural Oncology plc (NasdaqGM: MURA) at USD -192.72 M.